Atom Investors’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
Atom Investors's ALPN Position: Q2 2024 in Review
Atom Investors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 22,721 shares — an estimated $901K sold.
Atom Investors first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $901K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Atom Investors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Atom Investors sold 22,721 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $901K.
- Atom Investors first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
- Atom Investors's Alpine Immune Sciences Inc position peaked at $901K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Atom Investors's 13F filing for Q2 2024, filed 14 Aug 2024.